3-Month, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy, Safety & Tolerability of Imatinib 400 Mg Daily in Combination With Methotrexate (MTX)Compared to MTX Alone in the Treatment of Rheumatoid Arthritis (RA).
Latest Information Update: 10 Nov 2021
Price :
$35 *
At a glance
- Drugs Imatinib (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Biomarker; Therapeutic Use
- Sponsors Novartis
- 11 Nov 2006 New trial record.